Search for instruments
Ironwood Pharmaceuticals Inc
Ironwood Pharmaceuticals Inc is a leading biotech firm that specializes in developing and commercializing innovative medicines to improve the lives of patients with gastrointestinal (GI) diseases and other conditions. Its flagship product, LINZESS, is a prescription medication that treats irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). Ironwood has a robust pipeline of potential new therapies in various stages of development, including treatments for gastroesophageal reflux disease (GERD), abdominal pain associated with IBS, and other GI disorders. The company is dedicated to advancing science and delivering breakthrough therapies that address unmet medical needs, with a mission to make a meaningful difference in the lives of patients and their families.Instrument specification in OANDA
Name
Currency
Symbol
Minimum order value
Ticker
Trading hours
Type
Hours of accepting orders
ISIN
Start trading now with fast account opening.
Sign-up now to trade the most active markets
Open account
Boasting over 20 years in the markets, leading analysis tools and thousands of satisfied clients, OANDA is proud to be an award-winning broker.
Get access to the most active of global markets with thousands of trading instruments at your fingertips, as well leading technical tools to assist in your analysis.
Trade without unnecessary costs and total pricing transparency - OANDA offers zero-commission on major instruments, transparent pricing.
